echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Enzyme Technology > Six areas with the highest degree of automation in biomedical industry

    Six areas with the highest degree of automation in biomedical industry

    • Last Update: 2015-07-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    July 7, 2015 / BIOON / - market research company markets and markets research believes that the annual research volume of compounds will grow at a rate of 6.7%, and it is expected that the global industrial value of experimental automation will increase to US $5.106 billion in 2020 Kalorama research believes that this estimate is too conservative, because in 2014 alone, the total sales of clinical laboratory instruments reached US $5.4 billion However, both research companies believe that the main reasons for the growth of automation industry are as follows: miniaturization of equipment, large sample size, progress in drug research and clinical diagnosis, improvement of experimental reproducibility and accuracy, and the gap between supply and demand still exists The fundamental reason of industrial growth lies in: increasing workload, improving efficiency and reducing cost The following are the top six aspects of automation In the research and development process of liquid treatment drugs, the number of candidate drugs can reach millions, and liquid treatment has always been a very important link in this field The volume of liquid can be fixed or adjusted by using automatic technology, ranging from 4, 6, 8, 12, 96384 to 1536 parts, and the efficiency is greatly improved In addition, pipeline operation can ensure the continuity and reliability of the process and avoid human error People's pursuit of reducing costs and improving efficiency has greatly promoted the development of this technology Automatic sample detection can increase the number of samples without increasing the cost The experimental results are often inaccurate because of wrong label, inaccurate sample loading and improper container selection In reading the sample information and determining whether the sample is suitable for testing, there will also be errors If errors can be detected as early as possible, samples can be replaced or disposed of, the loss can be minimized Packaging biomedical industry is gradually fully automated The existing semi-automatic packaging technology may still bring great errors If fully automated packaging technology is adopted, a multinational vaccine manufacturer expects that the success rate of packaging will be increased from 62% to 99% Automation technology can reduce labor costs by an average of 35% Before sample processing (including storage and taking), sample processing, storage and taking were all completed manually according to relevant regulations After automation, the whole operation process will be divided into two parts: the instrument designed according to the sample processing process and the system to complete the automation process Driven by the following factors, the development of sample processing automation is rapid: the average annual increase of detection volume is 10% - 15%, the aging of population, the innovation of detection means, the requirements of sample pollution prevention, the need to detect multiple drug-resistant microorganisms, the limited number of technicians, and the reduction of detection time required by epidemic Experimental data recording many experiments rely on instruments, such as DNA sequence detection and replication Can we do experiments and record experimental data automatically? In the past three years, with the efforts of some start-ups, all this is becoming a reality The order of the experiments is arranged by the researchers Through the remote control of the computer, the robot will guide the relevant instruments to complete the experiments Software and robots also make great contributions to the storage of experimental data In the field of compound screening biomedicine, high-throughput drug screening is needed The key to the development of this technology is robot, detector and software Ten years ago, a company increased the number of screened compounds from 100 to 200 in a week to 2000 to 5000 However, as of 2011, ultra high throughput screening can detect 100000 drugs a day (BIOON Com) original link: Six laboratory tasks supplied by automation
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.